Mohammad Amin Abazari

Dr. Mohammad Amin Abazari

K.N.Toosi University of Technology, Tehran, Tehrān, Iran

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MAMohammad Amin Abazari
Mohammad Amin Abazari
DRDeniz Rafieianzab
Deniz Rafieianzab
MSMadjid Soltani
Madjid Soltani
MAMona Alimohammadi
Mona Alimohammadi
Aortic dissection (AD) is one of the fatal and complex conditions. Since there is a lack of a specific treatment guideline for type-B AD, a better understanding of patient-specific hemodynamics and therapy outcomes can potentially control the progression of the disease and aid in the clinical decision-making process. In this work, a patient-specific geometry of type-B AD is reconstructed from computed tomography images, and a numerical simulation using personalised computational fluid dynamics (CFD) with three-element Windkessel model boundary condition at each outlet is implemented. According to the physiological response of beta-blockers to the reduction of left ventricular contractions, three case studies with different heart rates are created. Several hemodynamic features, including time-averaged wall shear stress (TAWSS), highly oscillatory, low magnitude shear (HOLMES), and flow pattern are investigated and compared between each case. Results show that decreasing TAWSS, which is caused by the reduction of the velocity gradient, prevents vessel wall at entry tear from rupture. Additionally, with the increase in HOLMES value at distal false lumen, calcification and plaque formation in the moderate and regular-heart rate cases are successfully controlled. This work demonstrates how CFD methods with non-invasive hemodynamic metrics can be developed to predict the hemodynamic changes before medication or other invasive operations. These consequences can be a powerful framework for clinicians and surgical communities to improve their diagnostic and pre-procedural planning.

17 June 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DRDeniz Rafieianzab
Deniz Rafieianzab
MAMohammad Amin Abazari
Mohammad Amin Abazari
MSM. Soltani
M. Soltani
MAMona Alimohammadi
Mona Alimohammadi
Coarctation of the aorta (CoA) is a congenital tightening of the proximal descending aorta. Flow quantification can be immensely valuable for an early and accurate diagnosis. However, there is a lack of appropriate diagnostic approaches for a variety of cardiovascular diseases, such as CoA. An accurate understanding of the disease depends on measurements of the global haemodynamics (criteria for heart function) and also the local haemodynamics (detailed data on the dynamics of blood flow). Playing a significant role in clinical processes, wall shear stress (WSS) cannot be measured clinically; thus, computation tools are needed to give an insight into this crucial haemodynamic parameter. In the present study, in order to enable the progress of non-invasive approaches that quantify global and local haemodynamics for different CoA severities, innovative computational blueprint simulations that include fluid–solid interaction models are developed. Since there is no clear approach for managing the CoA regarding its severity, this study proposes the use of WSS indices and pressure gradient to better establish a framework for treatment procedures in CoA patients with different severities. This provides a platform for improving CoA therapy on a patient-specific level, in which physicians can perform treatment methods based on WSS indices on top of using a mere experience. Results show how severe CoA affects the aorta in comparison to the milder cases, which can give the medical community valuable information before and after any intervention.

1 January 2023 in Physics of Fluids
Verified
Journal Article
Closed access
PDF file
MAMohammad Amin Abazari
Mohammad Amin Abazari
MSMadjid Soltani
Madjid Soltani
FKFarshad Moradi Kashkooli
Farshad Moradi Kashkooli
Targeted drug delivery to cancer cells utilizing antibodies against oncogenic cell-surface receptors is an emerging therapeutical approach. Here, we developed a computational framework to evaluate the treatment efficacy of free Doxorubicin (Dox) and immunoliposome at different stages of vascular solid tumors. First, three different stages of vascularized tumor progression with various microvascular densities (MVDs) are generated using mathematical modeling of tumor-induced angiogenesis. Fluid flow in vascular and interstitial spaces is then calculated. Ultimately, convection-diffusion-reaction equations governing on classical chemotherapy (stand-alone Dox) and immunochemotherapy (drug-loaded nanoparticles) are separately solved to calculate the spatiotemporal concentrations of therapeutic agents. The present model considers the key processes in targeted drug delivery, including association/disassociation of payloads to cell receptors, cellular internalization, linker cleavage, intracellular drug release, and bystander-killing effect. Reducing MVD led to a decrease in the interstitial fluid pressure, allowing higher rates of the drug to enter the intratumoral environment. The current model also confirms the heterogeneous accumulation of Dox in the perivascular regions during classical chemotherapy. On the other hand, immunoliposomes exhibiting bystander-killing effect yield higher drug internalization during immunochemotherapy. The bystander-killing effect alongside intracellular Dox release and persistence of immunoliposomes within tumor over a longer period lead to more homogeneous drug distribution and a much greater fraction of killed cancer cells than the stand-alone chemotherapy. Present results can be used to improve the treatment efficacy of drug delivery at different stages of vascular tumors.

3 June 2022 in Cancers
Verified
Journal Article
Open access
PDF file
MAMohammad Amin Abazari
Mohammad Amin Abazari
MSMadjid Soltani
Madjid Soltani
FKFarshad Moradi Kashkooli
Farshad Moradi Kashkooli
Kaamran RaahemifarKaamran Raahemifar
Kaamran Raahemifar
No previous works have attempted to combine generative adversarial network (GAN) architectures and the biomathematical modeling of positron emission tomography (PET) radiotracer uptake in tumors to generate extra training samples. Here, we developed a novel computational model to produce synthetic 18F-fluorodeoxyglucose (18F-FDG) PET images of solid tumors in different stages of progression and angiogenesis. First, a comprehensive biomathematical model is employed for creating tumor-induced angiogenesis, intravascular and extravascular fluid flow, as well as modeling of the transport phenomena and reaction processes of 18F-FDG in a tumor microenvironment. Then, a deep convolutional GAN (DCGAN) model is employed for producing synthetic PET images using 170 input images of 18F-FDG uptake in each of 10 different tumor microvascular networks. The interstitial fluid parameters and spatiotemporal distribution of 18F-FDG uptake in tumor and healthy tissues have been compared against previously published numerical and experimental studies, indicating the accuracy of the model. The structural similarity index measure (SSIM) and peak signal-to-noise ratio (PSNR) of the generated PET sample and the experimental one are 0.72 and 28.53, respectively. Our results demonstrate that a combination of biomathematical modeling and GAN-based augmentation models provides a robust framework for the non-invasive and accurate generation of synthetic PET images of solid tumors in different stages.

12 September 2024 in Biomedical Physics & Engineering Express
Verified
Journal Article
Open access
MAMohammad Amin Abazari
Mohammad Amin Abazari
MSMadjid Soltani
Madjid Soltani
FEFaezeh Eydi
Faezeh Eydi
ARArman Rahmim
Arman Rahmim
FKFarshad Moradi Kashkooli
Farshad Moradi Kashkooli
18F-Fluoromisonidazole (18F-FMISO) is a highly promising positron emission tomography radiopharmaceutical for identifying hypoxic regions in solid tumors. This research employs spatiotemporal multi-scale mathematical modeling to explore how different levels of angiogenesis influence the transport of radiopharmaceuticals within tumors. In this study, two tumor geometries with heterogeneous and uniform distributions of capillary networks were employed to incorporate varying degrees of microvascular density. The synthetic image of the heterogeneous and vascularized tumor was generated by simulating the angiogenesis process. The proposed multi-scale spatiotemporal model accounts for intricate physiological and biochemical factors within the tumor microenvironment, such as the transvascular transport of the radiopharmaceutical agent, its movement into the interstitial space by diffusion and convection mechanisms, and ultimately its uptake by tumor cells. Results showed that both quantitative and semi-quantitative metrics of 18F-FMISO uptake differ spatially and temporally at different stages during tumor growth. The presence of a high microvascular density in uniformly vascularized tumor increases cellular uptake, as it allows for more efficient release and rapid distribution of radiopharmaceutical molecules. This results in enhanced uptake compared to the heterogeneous vascularized tumor. In both heterogeneous and uniform distribution of microvessels in tumors, the diffusion transport mechanism has a more pronounced than convection. The findings of this study shed light on the transport phenomena behind 18F-FMISO radiopharmaceutical distribution and its delivery in the tumor microenvironment, aiding oncologists in their routine decision-making processes.

13 October 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MAMohammad Amin Abazari
Mohammad Amin Abazari
MSMadjid Soltani
Madjid Soltani
FKFarshad Moradi Kashkooli
Farshad Moradi Kashkooli
Targeted drug delivery to cancer cells utilizing antibodies against oncogenic cell-surface receptors is an emerging therapeutical approach. Here, we developed a computational framework to evaluate the treatment efficacy of free Doxorubicin (Dox) and immunoliposome at different stages of vascular solid tumors. Firstly, three stages of vascularized tumors with different microvascular densities (MVDs) are generated using mathematical modeling of tumor-induced angiogenesis. Secondly, the fluid flow in vascular and interstitial spaces is calculated. Ultimately, convection-diffusion-reaction equations governing on classical chemotherapy (stand-alone Dox) and immunochemotherapy (drug-loaded nanoparticles) are separately solved to calculate the spatiotemporal concentrations of different therapeutic agents. The present model considers the key processes in targeted drug delivery, including association/disassociation of payloads to cell receptors, cellular internalization, linker cleavage, intracellular drug release, and bystander-killing effect. Our results show that reducing MVD decreases the interstitial fluid pressure, allowing higher rates of the drug to enter the tumor microenvironment. Also, immunoliposomes exhibiting bystander-killing effect yield higher drug internalization, which supports a higher intracellular Dox concentration during immunochemotherapy. Bystander-killing effect alongside intracellular Dox release and persistence of immunoliposomes within tumor over a longer period lead to more homogeneous drug distribution and a much greater fraction of killed cancer cells than classical chemotherapy. Our findings also demonstrate drug transport at tumor microvascular networks is increased by decreasing MVD, leading to better treatment outcomes. Present results can be used to improve the treatment efficacy of drug delivery at different stages of vascular tumors.